Palatin Technologies Inc (PTN)

0.587
+0.0139(+2.43%)
After Hours
0.5779
-0.0091(-1.5503%)
- Real-time Data
  • Volume:
    1,480,789
  • Bid/Ask:
    0.573/0.5779
  • Day's Range:
    0.556 - 0.587

PTN Overview

Prev. Close
0.5731
Day's Range
0.556-0.587
Revenue
-360,000
Open
0.5725
52 wk Range
0.375-1.3
EPS
-0.11
Volume
1,480,789
Market Cap
135.04M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,846,289
P/E Ratio
-
Beta
1.39
1-Year Change
11.64%
Shares Outstanding
230,049,691
Next Earnings Date
Sep 27, 2021
What is your sentiment on Palatin Technologies Inc?
or
Market is currently closed. Voting is open during market hours.

Palatin Technologies Inc News

Palatin Technologies Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyNeutralStrong Sell
Technical IndicatorsBuyStrong BuyStrong BuySellSell
SummaryStrong BuyStrong BuyStrong BuyNeutralStrong Sell

Palatin Technologies Inc Company Profile

Palatin Technologies Inc Company Profile

Employees
20

Palatin Technologies, Inc. (Palatin) is a biopharmaceutical company. The Company is engaged in developing medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. The Company’s product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical need and commercial potential. The melanocortin receptor (MCr) system is hormone driven, with effects on food intake, metabolism, sexual function, inflammation and immune system responses. There are five melanocortin receptors, MC1r through MC5r. The natriuretic peptide receptor (NPR) system regulates cardiovascular functions, and therapeutic agents modulating this system have potential to treat fibrotic diseases, cardiovascular diseases, including reducing cardiac hypertrophy and fibrosis, heart failure, acute asthma, pulmonary diseases and hypertension.

Read More
  • It goes always up 2% after hours. If you buy at regular hours and sell it after, it's 500% return per year. :)
    0
    • the guys that gave 2.3 as target to this stock...should be arrested !!!!
      0
      • if that is the case, then wall street will be empty...lol
        0
    • Major Green MONDAY!!!
      0
      • Can't find any news, what's the reason?
        0
    • Got in at 1.06.... i’m liking it!
      0
      • on buy and hold for long time, nice potential and target for this company 👍
        1
        • Somebody here?
          0
          • Very nice movement upwards. I hope this runs swiftly to 2-3 Dollars. Got in a bit late and only have 25% profit but let´s roll.
            0
            • $3 prob end of year
              0
          • Any comments?
            0
            • It just broke down?
              0
              • Wow.... $3 target price.... It's 200% return....
                0
                • Between $2 & $3  : https://www.tipranks.com/stocks/ptn/forecast
                  0
                  • This isGoing to 3$ minimum!
                    0
                    • hi Private Banker, you noted gonna to $3 min based on reports, your research, thanks as I'm thinking of investing in this stock
                      0
                  • Wow...target?
                    0
                    • 0.7
                      0
                    • 3
                      0
                  • Rocket started engine... go go go...
                    0
                    • very good company... certainly good to keep for long term
                      0
                      • Fly now,✔️✔️✔️
                        0
                        • buy buy..if breaks 0.485 🚀🚀🚀🚀
                          0
                          • Sleeping Beauty!!!
                            0
                            • Beauty 👎 😡I lose 40% from 0.61
                              0
                            • poia einai i apopsi sas Kyrie Philippe gia tHn Pfizer ?
                              0
                            • you only lose if you sell
                              0
                          • 28 US dollar is the fair value for the company
                            0
                            • My valuation tool says that, as well lol :D not that much really, but considering how they are creating value from cash and good drugs in pipe, 2-3$ easily in a few years.
                              0
                          • I think the turn is v. near for PTN.. I started with TNXP @ this level ... sold and bought PTN??
                            0
                            • On fire right now.
                              0
                              • Should i get in now?
                                0
                            • 🚀🚀🚀
                              0
                              • I like $HTBX because its stock price is up by more than 500% since March when the medical research firm announced COVID-19-related developments. I like $PTN because they said it would test one of its investigational drugs as a treatment for COVID-19. The PTN plans to submit an investigational new drug application in the third quarter of the year and initiate a Phase 2 randomized, controlled clinical trial for hospitalized adult COVID-19 patients with hypoxemic respiratory failure in the fourth quarter. $HTBX is 2.90 a share and $PTN is .53 cents a share with a STRONG BUY rating and target of 3.00.
                                0
                                • PE under 5 still, ROIC% and ROE support profitable growth over cost of capital. They have a new drug licensed with Amag pharmaceuticals. I don't understand why this hasn't taken off already big time. Nasdaq analysts estimate 2,5$ fair price, simply wall street a whopping 24$ (yea, that's too much) but still...
                                  0
                                  • doess anyone knows what is going on with Palating
                                    0
                                    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.